BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21251065)

  • 1. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
    Chen Z; Huo JR; Yang L; Zhu HY
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1016-21. PubMed ID: 21251065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
    Wang Y; Qiao D; Li Y; Xu F
    BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical condition evaluation of hepatic veno-occlusive disease induced by gynura segetum].
    Wu XJ; Yu MY; Yan YW
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):635-6. PubMed ID: 24163873
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
    J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Salvia miltiorrhiza in a mouse model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
    Yang L; Huo JR; Zhu HY; Chen Z; Wang XY
    Rev Esp Enferm Dig; 2019 Nov; 111(11):823-827. PubMed ID: 31566407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematologic toxicity of Gynura segetum and effects on vascular endothelium in a rat model of hepatic veno-occlusive disease].
    Fang J; Zhang G; Teng X; Zhang Z; Pan J; Shou Q; Chen M
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):59-63. PubMed ID: 25751389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic veno-occlusive disease related to Gynura segetum: A case report.
    Sun Z; Kang J; Zhang Y
    Medicine (Baltimore); 2018 Apr; 97(17):e0552. PubMed ID: 29703039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
    Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.
    Zhang H; Jia S; Jin L; Mb JY; Shen Z; Wu J; Yao X; Chen D; Zhang C; Yu S; Zhu N; Jin L; Yao X
    Acta Cir Bras; 2022; 36(11):e361104. PubMed ID: 35195181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the hepatic veno-occlusive disease models induced by gynura segetum, monocrotaline and cyclophosphamide].
    Yang L; Zhu HY; Chen Z; Huo JR
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):944-5. PubMed ID: 21205486
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of patients with hepatic veno-occlusive disease induced by Gynura segetum: A retrospective study.
    Feng MX; Shen Y; Lu YQ
    J Integr Med; 2020 Sep; 18(5):434-440. PubMed ID: 32773246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline.
    Chen MY; Cai JT; Du Q; Wang LJ; Chen JM; Shao LM
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):395-400. PubMed ID: 18693175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
    Borowska H; Arciszewska E; Czauderna P; Sawicki B
    Folia Morphol (Warsz); 2004 Feb; 63(1):91-3. PubMed ID: 15039909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
    DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
    Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature.
    Dai N; Yu YC; Ren TH; Wu JG; Jiang Y; Shen LG; Zhang J
    World J Gastroenterol; 2007 Mar; 13(10):1628-31. PubMed ID: 17461462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with danhong injection for hepatic veno-occlusive disease.
    Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
    Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
    Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
    J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
    Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
    J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation.
    Zeng L; An L; Fang T; Pan B; Sun H; Chen C; Cao J; Li Z; Xu K
    Cell Biochem Biophys; 2013; 67(3):939-48. PubMed ID: 23579582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.